MRK dividend yield: 3.25%. XYLD dividend yield: 9.02%. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s. XYLD sells covered calls on the S&P 500, converting equity volatility into monthly income. Yields 8-10% depending on market conditions. Similar to QYLD but with S&P 500 exposure — less volatile but comparable income mechanics. Popular for retirement income portfolios alongside other dividend ETFs.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
XYLD sells covered calls on the S&P 500, converting equity volatility into monthly income. Yields 8-10% depending on market conditions. Similar to QYLD but with S&P 500 exposure — less volatile but comparable income mechanics. Popular for retirement income portfolios alongside other dividend ETFs.
Is MRK or XYLD better for dividend income in 2026?
MRK currently offers a 3.25% yield (3.08/share/year) while XYLD offers 9.02% (3.48/share/year). XYLD provides higher current income. However, MRK has grown its dividend faster (8.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs XYLD earn per year?
With $10,000 invested today: MRK pays approximately $325/year. XYLD pays approximately $902/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $2,364/year (XYLD).
Does MRK or XYLD pay monthly dividends?
MRK pays quarterly dividends. XYLD pays monthly dividends. XYLD pays monthly, which is preferred by investors who need regular cash flow.
📬
Get this MRK vs XYLD comparison by email
Save your analysis + get weekly dividend insights. Free forever.